It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Genetic testing for Parkinson’s disease (PD) is increasing globally, and genetic counseling is an important service that provides information and promotes understanding about PD genetics and genetic testing. PD research studies have initiated outreach to underrepresented regions in North America, including regions in Latin America, such as the Dominican Republic (DR); some studies may include return of genetic test results. Thus, understanding what individuals know about PD, genetic testing for PD, and their interest in speaking with a genetic counselor, is crucial when assessing readiness. In this cross-sectional study, a survey was distributed to people with Parkinson’s disease (PwP) and their unaffected biological relatives in the DR. Questions assessed genetics knowledge, attitude toward genetic testing, and interest in genetic testing and counseling. Of 45 participants, 69% scored the maximum on the attitude scale, indicating an overall positive attitude toward genetic testing; 95% indicated interest in genetic testing for PD, and 98% were at least somewhat interested in meeting with a genetic counselor. The mean PD genetics knowledge score was similar to previously published data. Through free text responses, participants expressed a desire to know more about PD treatment and management, prevention, cause, and their personal risk for PD. These results provide further evidence of readiness for genetic testing in this country but also underscore some gaps in knowledge that should be addressed with targeted educational efforts, as part of building genetic testing and counseling capacities.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details




1 Indiana University School of Medicine, Department of Medical and Molecular Genetics, Indianapolis, USA (GRID:grid.257413.6) (ISNI:0000 0001 2287 3919); Medical College of Wisconsin, Department of Obstetrics and Gynecology, Milwaukee, USA (GRID:grid.30760.32) (ISNI:0000 0001 2111 8460)
2 Indiana University School of Medicine, Department of Medical and Molecular Genetics, Indianapolis, USA (GRID:grid.257413.6) (ISNI:0000 0001 2287 3919)
3 Indiana University School of Medicine, Department of Medical and Molecular Genetics, Indianapolis, USA (GRID:grid.257413.6) (ISNI:0000 0001 2287 3919); Indiana University School of Medicine, Department of Neurology, Section of Child Neurology, Indianapolis, USA (GRID:grid.257413.6) (ISNI:0000 0001 2287 3919); Indiana University School of Medicine, Department of Pediatrics, Indianapolis, USA (GRID:grid.257413.6) (ISNI:0000 0001 2287 3919)
4 Parkinson’s Foundation, New York, USA (GRID:grid.453428.c) (ISNI:0000 0001 2236 2879)
5 Centro Cardio-Neuro-Oftalmológico y Trasplante (CECANOT), Santo Domingo, Dominican Republic (GRID:grid.453428.c)